Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma
Authors:
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 279, 119359
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Thrombin Induces CCL2 Expression in Human Lung Fibroblasts via p300 Mediated Histone Acetylation and NF‐KappaB ActivationJournal of Cellular Biochemistry, 2017
- Combination therapy in combating cancerOncotarget, 2017
- Thrombin Activates Latent TGFβ1 via Integrin αvβ1 in Gingival FibroblastsJournal of Dental Research, 2016
- Immunotherapy for hepatocellular carcinomaDrug Discoveries & Therapeutics, 2015
- Anticoagulant activities of curcumin and its derivativeBMB Reports, 2012
- Thrombin is a Therapeutic Target for Metastatic Osteopontin-Positive Hepatocellular CarcinomaHepatology, 2010
- Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 ExpressionJournal of Virology, 2007
- Increased expression of integrin β1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300‐mediated histone acetylation in human hepatocellular carcinoma cellsJournal of Cellular Biochemistry, 2007
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- p53-Mediated Repression of Alpha-Fetoprotein Gene Expression by Specific DNA BindingMolecular and Cellular Biology, 1999